1. Expression of homeodomain protein CDX2 in gallbladder carcinomas

   • Xiang-Song Wu
   • Yoshimitsu Akiyama
   • Yasuhito Yuasa

   Original Paper 11 January 2005 Pages: 271 - 278

   

2. Analyses of minimal residual disease based on Flt3 mutations in allogeneic peripheral blood stem cell transplantation

   • Sebastian Scholl
   • Ivan F. Loncarevic
   • Herbert G. Sayer

   Original Paper 11 January 2005 Pages: 279 - 283

   

3. The prognostic factor for outcome following second resection for intrahepatic recurrence of hepatocellular carcinoma with a hepatitis B virus infection background

   • Hui-Chuan Sun
   • Zhao-You Tang
   • Xin-Da Zhou

   Original Paper 21 January 2005 Pages: 284 - 288

   

4. Combination treatment of CC531-lac-Z rat liver metastases by chemoembolization with pemetrexed disodium and gemcitabine

   • Michael Rodenbach
   • Ergül Eyol
   • Martin R. Berger

   Original Paper 19 January 2005 Pages: 289 - 299

   

5. Oral capecitabine plus subcutaneous interferon alpha in advanced squamous cell carcinoma of the skin

   • Uwe Wollina
   • Gesina Hansel
   • Erich Köstler

   Original Paper 24 December 2004 Pages: 300 - 304

   

6. New tumor necrosis factor-α-inducing protein released from Helicobacter pylori for gastric cancer progression

   • Masami Suganuma
   • Miki Kurusu
   • Hirota Fujiki

   Original Paper 23 December 2004 Pages: 305 - 313

   

7. Glucocorticoids induce G1 cell cycle arrest in human neoplastic thymic epithelial cells

   • Yasunobu Funakoshi
   • Hiroyuki Shiono
   • Tadaaki Eimoto

   Original Paper 10 February 2005 Pages: 314 - 322

   

8. Characterization of the combined cellular survival effects of benzoquinone-ansamycins and ionizing radiation

   • Hans-Joachim Ochel
   • Günther Gademann

   Original Paper 08 December 2004 Pages: 323 - 328

   

9. Treosulfan and gemcitabine

   • Ian A. Cree
   • Michael H. Neale
   • Christian M. Kurbacher

   Letter to the Editor 08 February 2005 Pages: 329 - 330

10. Reply concerning “Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma” by Terheyden et al. (2004)

    • P. Terheyden
    • E.-B. Bröcker
    • J. C. Becker

    Letter to the Editors 10 February 2005 Pages: 331 - 331